Nathalie Auger
Institut Gustave Roussy(FR)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, PARP inhibition in cancer therapy, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial(2017)760 cited
- → A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays(2007)408 cited
- → EGFR-independent mechanisms of acquired resistance to AZD9291 in EGFR T790M-positive NSCLC patients(2015)312 cited
- → Detection of Circulating Tumor Cells Harboring a Unique ALK Rearrangement in ALK-Positive Non–Small-Cell Lung Cancer(2013)279 cited
- → Clinical and Translational Implications of RET Rearrangements in Non–Small Cell Lung Cancer(2017)220 cited
- → Molecular profiling of patient-derived breast cancer xenografts(2012)190 cited
- → Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study(2016)183 cited
- → Accumulation of Segmental Alterations Determines Progression in Neuroblastoma(2010)167 cited
- → Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer(2019)166 cited
- → Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial(2017)165 cited